Clinical Trial Update: An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate in Males [Phase 1]

View source ↗

Summary

Open-label Phase 1 study assessing absorption, metabolism, and excretion of radiolabeled telotristat etiprate in male participants with carcinoid syndrome has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Syndrome

Drugs mentioned

• Telotristat Etiprate (telotristat etiprate)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Carcinoid Syndrome | Phase 1 | Status: COMPLETED